Pierre Loulergue

Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations

Pierre Loulergue, Flore Moulin, G. Vidal-Trécan et al. · Vaccine · 2009 · 167 citations

Vaccinology, Vaccine Safety, Vaccination +10

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 164 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +8

Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections

A. Hot, C. Maunoury, S. Poirée et al. · Clinical Microbiology and Infection · 2010 · 157 citations · Full text

Positron Emission Tomography, Diagnostic Mycology, Molecular Diagnostic Techniques +6

Literature Review and Case Histories of<i>Histoplasma capsulatum</i>var.<i>duboisii</i>Infections in HIV-infected Patients

Pierre Loulergue, Frédéric Bastides, Véronique Baudouin et al. · Emerging infectious diseases · 2007 · 148 citations · Full text

PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study

Sodiomon B. Sirima, Laura Richert, Arnaud Chêne et al. · The Lancet Infectious Diseases · 2020 · 122 citations · Full text

Vaccination, Vaccinology, Maternal Immunization +9